These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 209798)

  • 21. The effects of carbohydrate, fat and total energy adjustment of Fredrickson's type IIb hyperlipoproteinaemia.
    Watermeyer GS; Manning E
    S Afr Med J; 1977 Jan; 51(3):71-3. PubMed ID: 189446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta- and pre-beta-lipoproteins in coronary disease and hyperlipoproteinaemia.
    Billimoria JD; Makin J; Meerloo JM
    Atherosclerosis; 1979 May; 33(1):141-4. PubMed ID: 223598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of the electrophoretic pattern of type IV hyperlipidaemia to type III by intravenous heparin.
    Olsson AG; Carlson LA; Carlson K
    Acta Med Scand; 1978; 203(6):487-90. PubMed ID: 208351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein of the density 1.006-1.020 in the plasma of patients with type III hyperlipoproteinaemia in the postabsorptive state.
    Patsch JR
    Eur J Clin Invest; 1975 Feb; 5(1):45-55. PubMed ID: 164351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemia.
    Weisweiler P; Schwandt P
    Atherosclerosis; 1978 Sep; 31(1):53-8. PubMed ID: 213086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
    Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia.
    Ballantyne FC; Bedford DK; Ballantyne D; Third JL; Stromberg P; Packard CJ
    Clin Chim Acta; 1977 Mar; 75(3):487-90. PubMed ID: 192494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triglyceride-poor very low density lipoprotein in human serum.
    Reiner Z; Koren E
    Clin Chim Acta; 1979 May; 94(1):23-9. PubMed ID: 222511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xanthomatosis and other clinical findings in patients with elevated levels of very low density lipoproteins.
    Vermeer BJ; van Gent CM; Goslings B; Polano MK
    Br J Dermatol; 1979 Jun; 100(6):657-66. PubMed ID: 223620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characteristics of human plasma lipoprotein metabolism: influence of low caloric diet on hyperlipidemia.
    Nanbu S; Yamasaki S; Kimura N; Gohda H; Ageta M; Kariya S; Kamogawa T
    Adv Exp Med Biol; 1977; 82():279-82. PubMed ID: 200096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
    Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
    Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.